Alterations in brain metabolism during the first year of HIV infection.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMC 3753682)

Published in J Neurovirol on April 15, 2011

Authors

Margaret R Lentz1, Woong-Ki Kim, Hyun Kim, Caroline Soulas, Vallent Lee, Nagagopal Venna, Elkan F Halpern, Eric S Rosenberg, Kenneth Williams, R G González

Author Affiliations

1: Department of Neuroradiology and the A. A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, Boston, USA. mlentz@nmr.mgh.harvard.edu

Articles citing this

HIV-associated neurocognitive disorder. Lancet Infect Dis (2013) 1.60

HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med (2012) 1.34

Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS One (2012) 1.25

Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol (2013) 1.15

Speed of processing training with middle-age and older adults with HIV: a pilot study. J Assoc Nurses AIDS Care (2012) 1.14

Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep (2015) 1.03

Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol (2012) 1.03

Assessing and treating forgetfulness and cognitive problems in adults with HIV. J Assoc Nurses AIDS Care (2013) 0.92

HIV and neurocognitive dysfunction. Curr HIV/AIDS Rep (2013) 0.91

Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol (2013) 0.90

Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection. J Neuroimmune Pharmacol (2013) 0.90

Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology (2014) 0.88

Role of neuroimaging in HIV-associated neurocognitive disorders. Semin Neurol (2014) 0.88

Neuroimaging of HIV-associated neurocognitive disorders (HAND). Curr Opin HIV AIDS (2014) 0.88

Cerebral white matter integrity during primary HIV infection. AIDS (2015) 0.85

Determinants of HIV-induced brain changes in three different periods of the early clinical course: A data mining analysis. Neuroimage Clin (2015) 0.83

Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection. J Neuroimmune Pharmacol (2014) 0.83

Quantitative MRI Measures in SIV-Infected Macaque Brains. J Clin Cell Immunol (2013) 0.82

Can Speed of Processing Training Ameliorate Depressive Symptomatology in Adults with HIV? Ann Depress Anxiety (2014) 0.80

Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy. Neuroradiology (2012) 0.79

Early suppressive antiretroviral therapy in HIV infection is associated with measurable changes in the corpus callosum. J Neurovirol (2014) 0.78

Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb. J Neurovirol (2014) 0.78

Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy. J Acquir Immune Defic Syndr (2016) 0.77

Neurobehavioral Disturbances During Acute and Early HIV Infection. Cogn Behav Neurol (2016) 0.77

Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research. ISRN Nurs (2013) 0.77

Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation. Top Geriatr Rehabil (2014) 0.77

Early detection of simian immunodeficiency virus in the central nervous system following oral administration to rhesus macaques. Front Immunol (2013) 0.77

The role of neuroplasticity and cognitive reserve in aging with HIV: recommendations for cognitive protection and rehabilitation. J Neurosci Nurs (2013) 0.75

Dual-mixed HIV-1 coreceptor tropism and HIV-associated neurocognitive deficits. J Neurovirol (2013) 0.75

Topological organization of whole-brain white matter in HIV infection. Brain Connect (2017) 0.75

HIV and Cocaine Impact Glial Metabolism: Energy Sensor AMP-activated protein kinase Role in Mitochondrial Biogenesis and Epigenetic Remodeling. Sci Rep (2016) 0.75

A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV disease. Br J Radiol (2016) 0.75

Case control study: magnetic resonance spectroscopy of brain in HIV infected patients. BMC Neurol (2016) 0.75

Articles cited by this

Decay characteristics of HIV-1-infected compartments during combination therapy. Nature (1997) 13.68

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68

Immune control of HIV-1 after early treatment of acute infection. Nature (2000) 7.68

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90

Biological and virologic characteristics of primary HIV infection. Ann Intern Med (1998) 5.45

HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 3.17

The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol (2007) 2.41

Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology (2009) 2.08

Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology (1992) 2.07

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. Neuroimage (2004) 2.05

Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol (2006) 1.97

Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brain. Neurology (2009) 1.83

Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest (2005) 1.78

Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex. Neurology (1999) 1.71

Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol (2009) 1.70

Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology (1999) 1.58

Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology (1999) 1.49

Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infection. Clin Infect Dis (2006) 1.43

Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol (1991) 1.42

Neuropathology of early HIV-1 infection. Brain Pathol (1996) 1.37

Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol (2009) 1.34

In vivo 1H MRS of brain injury and repair during acute SIV infection in the macaque model of neuroAIDS. Magn Reson Med (2004) 1.26

Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J Virol (2007) 1.16

In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain. BMC Neurosci (2009) 1.16

Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology (1994) 1.15

Acute demyelinizating encephalomyelitis (ADEM) as initial presentation of primary HIV infection. Scand J Infect Dis (2007) 1.08

Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am J Neuroradiol (2005) 1.00

Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy. Eur J Radiol (2007) 0.98

[Case of acute primary HIV infection with menigoencephalitis demonstrating high signal intensity of the bilateral globus pallidus in T2-weighted MRI]. Rinsho Shinkeigaku (2007) 0.87

Magnetic resonance imaging and proton magnetic resonance spectroscopy of megalencephaly and dilated Virchow-Robin spaces. Pediatr Neurol (2006) 0.78

Articles by these authors

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61

Recognition of transmembrane helices by the endoplasmic reticulum translocon. Nature (2005) 7.72

Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol (2003) 6.98

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis (2008) 6.43

Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology (2003) 5.42

Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS (2003) 5.28

Characterization of human atherosclerosis by optical coherence tomography. Circulation (2002) 5.04

Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation (2003) 4.69

Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature (2007) 4.60

Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat Immunol (2007) 4.41

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol (2005) 4.38

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med (2004) 4.37

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA (2004) 4.36

Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J Virol (2004) 4.20

HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature (2002) 4.20

HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med (2006) 4.19

A rational approach to the stool ova and parasite examination. Clin Infect Dis (2006) 4.06

Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. Bioinformatics (2003) 3.78

Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med (2008) 3.48

Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol (2006) 3.28

Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis (2011) 3.25

In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation (2005) 3.23

Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120. Cell (2003) 3.03

Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis (2003) 2.92

NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. Nat Neurosci (2006) 2.91

Incomplete HIV type 1 antibody evolution and seroreversion in acutely infected individuals treated with early antiretroviral therapy. Clin Infect Dis (2005) 2.87

The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. Proc Natl Acad Sci U S A (1996) 2.85

Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging (2012) 2.72

HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med (2012) 2.72

Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol (2003) 2.53

Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol (2009) 2.51

Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood (2005) 2.50

Utilization of diagnostic medical imaging: comparison of radiologist referral versus same-specialty referral. Radiology (2007) 2.48

Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy. J Infect Dis (2011) 2.44

HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet (2004) 2.36

Application of recently developed computer algorithm for automatic classification of unstructured radiology reports: validation study. Radiology (2004) 2.36

Immune-driven recombination and loss of control after HIV superinfection. J Exp Med (2008) 2.34

Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol (2007) 2.32

Persistence of multiple illnesses in World Trade Center rescue and recovery workers: a cohort study. Lancet (2011) 2.24

Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets. Am J Hum Genet (2011) 2.22

Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol (2004) 2.21

Limited durability of viral control following treated acute HIV infection. PLoS Med (2004) 2.16

High-throughput fluorescent-based optimization of eukaryotic membrane protein overexpression and purification in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2007) 2.15

Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol (2002) 2.14

Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology (2012) 2.14

Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression. Eur Heart J (2006) 2.13

Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology (2009) 2.08

GFP-based optimization scheme for the overexpression and purification of eukaryotic membrane proteins in Saccharomyces cerevisiae. Nat Protoc (2008) 2.06

Noninvasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension. Circ Cardiovasc Imaging (2009) 2.05

Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci (2003) 2.05

Case records of the Massachusetts General Hospital. Case 11-2009. A 47-year-old man with fever, headache, rash, and vomiting. N Engl J Med (2009) 2.04

Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A (1997) 2.04

Geographic information system-based identification of suitable cultivation sites for wood-cultivated ginseng. J Ginseng Res (2013) 2.04

De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol (2005) 2.04

HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol (2009) 2.03

Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol (2004) 2.03

Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J (2006) 1.98

The effect of platelet-rich plasma on flap survival in random extension of an axial pattern flap in rabbits. Plast Reconstr Surg (2013) 1.98

CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques initial observations. Radiology (2002) 1.98

Consensus interpretation in imaging research: is there a better way? Radiology (2010) 1.94

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol (2011) 1.93

CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am J Pathol (2006) 1.92

Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J Virol (2006) 1.91

Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology (2005) 1.91

Amygdala depotentiation and fear extinction. Proc Natl Acad Sci U S A (2007) 1.91

Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis (2007) 1.91

HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J Virol (2010) 1.90

CT of colon cancer metastases to the liver using modified RECIST criteria: determining the ideal number of target lesions to measure. AJR Am J Roentgenol (2006) 1.89

Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog (2010) 1.89

HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS (2004) 1.89

Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J (2006) 1.88

Diffusion tensor MRI of myocardial fibers and sheets: correspondence with visible cut-face texture. J Magn Reson Imaging (2003) 1.88

A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med (2007) 1.88

CT and conventional and diffusion-weighted MR imaging in acute stroke: study in 691 patients at presentation to the emergency department. Radiology (2002) 1.85

Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS (2004) 1.85

Case volumes of intra-arterial and intravenous treatment of ischemic stroke in the USA. J Neurointerv Surg (2009) 1.82

Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization. AIDS (2003) 1.80

An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale. AJNR Am J Neuroradiol (2008) 1.80

Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem (2002) 1.79

Image-guided biopsy in the esophagus through comprehensive optical frequency domain imaging and laser marking: a study in living swine. Gastrointest Endosc (2009) 1.79

HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood (2004) 1.78

Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest (2005) 1.78

Effects of acute and chronic ethanol exposure on the behavior of adult zebrafish (Danio rerio). Pharmacol Biochem Behav (2006) 1.77

Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans. Cytometry A (2010) 1.76

Automated computer-assisted categorization of radiology reports. AJR Am J Roentgenol (2005) 1.74

H. M.'s medial temporal lobe lesion: findings from magnetic resonance imaging. J Neurosci (1997) 1.71

Clinical management of acute HIV infection: best practice remains unknown. J Infect Dis (2010) 1.71

CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest (2011) 1.71

Attenuation of acute and chronic pulmonary emboli. Radiology (2005) 1.69

CT perfusion mean transit time maps optimally distinguish benign oligemia from true "at-risk" ischemic penumbra, but thresholds vary by postprocessing technique. AJNR Am J Neuroradiol (2011) 1.68

Fine-needle aspiration biopsy of thyroid nodules: experience in a cohort of 944 patients. AJR Am J Roentgenol (2009) 1.68

Haptics in minimally invasive surgical simulation and training. IEEE Comput Graph Appl (2004) 1.67

The pattern of leptomeningeal collaterals on CT angiography is a strong predictor of long-term functional outcome in stroke patients with large vessel intracranial occlusion. Stroke (2010) 1.66

Programmed cell death of adult-generated hippocampal neurons is mediated by the proapoptotic gene Bax. J Neurosci (2004) 1.66

The status of appendiceal CT in an urban medical center 5 years after its introduction: experience with 753 patients. AJR Am J Roentgenol (2005) 1.66

SALM synaptic cell adhesion-like molecules regulate the differentiation of excitatory synapses. Neuron (2006) 1.66

Mammographic screening: patterns of use and estimated impact on breast carcinoma survival. Cancer (2004) 1.66

Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats. Exp Neurol (2006) 1.65

Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety (2005) 1.64